サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1418354

モルヒネ市場レポート：2030年までの動向、予測、競合分析

Morphine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 - page report | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

モルヒネ市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

モルヒネの動向と予測

世界のモルヒネ市場は、2024年から2030年にかけてCAGR 8.1％で成長する見込みです。この市場の主な促進要因は、がんやその他の疾患患者の急増と疼痛管理におけるモルヒネの利用拡大です。世界のモルヒネ市場の将来は、病院・診療所市場と外来手術センター市場に機会がありそうです。

モルヒネ市場の洞察

Lucintelの予測では、神経疾患の増加により、予測期間中、注射剤が最大セグメントであり続ける。

この市場において、病院・診療所は処方件数が多いため最大セグメントであり続ける。

北米は慢性疾患の急増により、予測期間中も最大地域であり続けるでしょう。

よくある質問

Q1.市場の成長予測は？

A1.世界のモルヒネ市場は、2024年から2030年にかけてCAGR 8.1％で成長する見込みです。

Q2.市場の成長に影響を与える主な促進要因は？

A2.この市場の主な促進要因は、がんやその他の疾患の急増と疼痛管理におけるモルヒネの利用拡大です。

Q3.市場の主要セグメントは？

A3.モルヒネ市場の将来は、病院・診療所市場と外来手術センター市場の機会により有望です。

Q4.市場の主要企業は？

A4.主なモルヒネ企業は以下の通り。

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health Care

Q5.今後、最大となる市場セグメントは？

A5.Lucintelは、神経疾患の増加により、予測期間中、注射剤が最大のセグメントであり続けると予測しています。

Q6.市場において、今後5年間に最大になると予想される地域は？

A6.北米は慢性疾患の急増により、予測期間中も最大地域であり続ける。

Q7.レポートのカスタマイズは可能？

A7.はい、Lucintelは追加費用なしで10%のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のモルヒネ市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のモルヒネ市場動向（2018-2023）と予測（2024-2030）
  • 剤形別の世界のモルヒネ市場
    • 注射
    • 経口錠剤
    • その他
  • 流通チャネル別の世界のモルヒネ市場
    • 病院薬局
    • 小売薬局
    • オンライン薬局
    • その他
  • 用途別の世界のモルヒネ市場
    • 疼痛管理
    • 下痢抑制剤
    • 風邪と咳の抑制剤
    • その他
  • 最終用途別の世界のモルヒネ市場
    • 病院と診療所
    • 外来手術センター
    • その他

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のモルヒネ市場
  • 北米のモルヒネ市場
  • 欧州のモルヒネ市場
  • アジア太平洋のモルヒネ市場
  • その他地域のモルヒネ市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略分析

  • 成長機会分析
    • 剤形別の世界モルヒネ市場の成長機会
    • 流通チャネル別の世界モルヒネ市場の成長機会
    • 用途別の世界モルヒネ市場の成長機会
    • 最終用途別の世界モルヒネ市場の成長機会
    • 地域別の世界モルヒネ市場の成長機会
  • 世界のモルヒネ市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界モルヒネ市場の生産能力拡大
    • 世界のモルヒネ市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health care
目次

Morphine Trends and Forecast

The future of the global morphine market looks promising with opportunities in the hospitals & clinics and ambulatory surgical centers markets. The global morphine market is expected to grow with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are surge in cancer and other disease cases accentuates and escalating utilization of morphine for pain management.

A more than 150-page report is developed to help in your business decisions.

Morphine by Segment

The study includes a forecast for the global morphine by dosage form, distrbution channel, application, end use, and region.

Morphine Market by Dosage Form [Shipment Analysis by Value from 2018 to 2030]:

  • Injection
  • Oral Tablets
  • Others

Morphine Market by Distrbution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Morphine Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Pain Management
  • Diarrhea Suppressant
  • Cold And Cough Suppressant
  • Others

Morphine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Morphine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Morphine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies morphine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the morphine companies profiled in this report include-

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health Care

Morphine Market Insights

Lucintel forecasts that injection will remain the largest segment over the forecast period due to growing occurrence of neurological diseases.

Within this market, hospitals and clinics will remain the largest segment due to high prescriptions.

North America will remain the largest region over the forecast period due to surging prevalence of chronic diseases.

Features of the Global Morphine Market

Market Size Estimates: Morphine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Morphine market size by various segments, such as by dosage form, distrbution channel, application, end use, and region in terms of value ($B).

Regional Analysis: Morphine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different dosage form, distrbution channel, application, end use, and regions for the morphine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the morphine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for morphine market?

Answer: The global morphine market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the morphine market?

Answer: The major drivers for this market are surge in cancer and other disease cases accentuates and escalating utilization of morphine for pain management.

Q3. What are the major segments for morphine market?

Answer: The future of the morphine market looks promising with opportunities in the hospitals & clinics and ambulatory surgical centers markets.

Q4. Who are the key morphine market companies?

Answer: Some of the key morphine companies are as follows.

  • Mallinckrodt Pharmaceuticals
  • Alcaliber
  • Purdue Pharma
  • Sanofi Winthrop Industries
  • Macfarlan Smith
  • Sun Pharmaceutical Industries
  • Qinghai Pharmaceutical
  • Northeast Pharmaceutical
  • Pfizer
  • Verve Health Care

Q5. Which morphine market segment will be the largest in future?

Answer: Lucintel forecasts that injection will remain the largest segment over the forecast period due to growing occurrence of neurological diseases.

Q6. In morphine market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surging prevalence of chronic diseases.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the morphine market by dosage form (injection, oral tablets, and others), distrbution channel (hospital pharmacies, retail pharmacies, online pharmacies, and others), application (pain management, diarrhea suppressant, cold and cough suppressant, and others), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Morphine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Morphine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Morphine Market by Dosage Form
    • 3.3.1: Injection
    • 3.3.2: Oral Tablets
    • 3.3.3: Others
  • 3.4: Global Morphine Market by Distrbution Channel
    • 3.4.1: Hospital Pharmacies
    • 3.4.2: Retail Pharmacies
    • 3.4.3: Online Pharmacies
    • 3.4.4: Others
  • 3.5: Global Morphine Market by Application
    • 3.5.1: Pain Management
    • 3.5.2: Diarrhea Suppressant
    • 3.5.3: Cold and Cough Suppressant
    • 3.5.4: Others
  • 3.6: Global Morphine Market by End Use
    • 3.6.1: Hospitals & Clinics
    • 3.6.2: Ambulatory Surgical Centers
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Morphine Market by Region
  • 4.2: North American Morphine Market
    • 4.2.3: North American Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.3: European Morphine Market
    • 4.3.1: European Morphine Market by Dosage Form: Injection, Oral Tablets, and Others
    • 4.3.3: European Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Morphine Market
    • 4.4.1: APAC Morphine Market by Dosage Form: Injection, Oral Tablets, and Others
    • 4.4.3: APAC Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Morphine Market
    • 4.5.1: ROW Morphine Market by Dosage Form: Injection, Oral Tablets, and Others
    • 4.5.3: ROW Morphine Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Morphine Market by Dosage Form
    • 6.1.2: Growth Opportunities for the Global Morphine Market by Distrbution Channel
    • 6.1.3: Growth Opportunities for the Global Morphine Market by Application
    • 6.1.4: Growth Opportunities for the Global Morphine Market by End Use
    • 6.1.5: Growth Opportunities for the Global Morphine Market by Region
  • 6.2: Emerging Trends in the Global Morphine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Morphine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Morphine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Mallinckrodt Pharmaceuticals
  • 7.2: Alcaliber
  • 7.3: Purdue Pharma
  • 7.4: Sanofi Winthrop Industries
  • 7.5: Macfarlan Smith
  • 7.6: Sun Pharmaceutical Industries
  • 7.7: Qinghai Pharmaceutical
  • 7.8: Northeast Pharmaceutical
  • 7.9: Pfizer
  • 7.10: Verve Health care